If I was to invest in another biotech something along the lines of MAP would be it. The enteric system is the future in healthcare. Given COVID, lockdowns and stress, prevalence in stress related conditions have increased like IBS. I believe MAP has a drug in phase 1 for IBS?
There is definite potential here. They are in the correct area for the future of healthcare as the enteric system is still a big unknown and lots of conditions do not have medicines that are effective.
Brought a parcel today.
Ann: Sonic Acquires 19.9% Microba Stake and Enters Partnership, page-19
Add MAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.89M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $6.638K | 40.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6782 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 41878 | 1 |
View Market Depth
| Last trade - 14.03pm 19/07/2024 (20 minute delay) ? |
| MAP (ASX) Chart |